{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260401721827/en/Merck-Announces-Initiation-of-Pivotal-Phase-2b3-Trial-Evaluating-MK-8748-Tiespectus-an-Investigational-Bispecific-Tie2-AgonistVEGF-Inhibitor-for-the-Treatment-of-Neovascular-Age-Related-Macular-Degeneration", "message": "News view counter 641891 successfully enlarged"}